233 related articles for article (PubMed ID: 16545582)
1. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.
Strafella AP; Ko JH; Monchi O
Neuroimage; 2006 Jul; 31(4):1666-72. PubMed ID: 16545582
[TBL] [Abstract][Full Text] [Related]
2. Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study.
Strafella AP; Ko JH; Grant J; Fraraccio M; Monchi O
Eur J Neurosci; 2005 Dec; 22(11):2946-52. PubMed ID: 16324129
[TBL] [Abstract][Full Text] [Related]
3. Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys.
Ohnishi T; Hayashi T; Okabe S; Nonaka I; Matsuda H; Iida H; Imabayashi E; Watabe H; Miyake Y; Ogawa M; Teramoto N; Ohta Y; Ejima N; Sawada T; Ugawa Y
Biol Psychiatry; 2004 Mar; 55(5):484-9. PubMed ID: 15023576
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: analysis of [11C] raclopride PET study.
Kim JY; Chung EJ; Lee WY; Shin HY; Lee GH; Choe YS; Choi Y; Kim BJ
Mov Disord; 2008 Jan; 23(2):207-11. PubMed ID: 17999422
[TBL] [Abstract][Full Text] [Related]
5. Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression.
Kuroda Y; Motohashi N; Ito H; Ito S; Takano A; Nishikawa T; Suhara T
J Affect Disord; 2006 Oct; 95(1-3):35-42. PubMed ID: 16781779
[TBL] [Abstract][Full Text] [Related]
6. Dopamine release in human ventral striatum and expectation of reward.
de la Fuente-Fernández R; Phillips AG; Zamburlini M; Sossi V; Calne DB; Ruth TJ; Stoessl AJ
Behav Brain Res; 2002 Nov; 136(2):359-63. PubMed ID: 12429397
[TBL] [Abstract][Full Text] [Related]
7. Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study.
Ko JH; Monchi O; Ptito A; Bloomfield P; Houle S; Strafella AP
Eur J Neurosci; 2008 Nov; 28(10):2147-55. PubMed ID: 19046396
[TBL] [Abstract][Full Text] [Related]
8. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
9. Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease.
Sacheli MA; Neva JL; Lakhani B; Murray DK; Vafai N; Shahinfard E; English C; McCormick S; Dinelle K; Neilson N; McKenzie J; Schulzer M; McKenzie DC; Appel-Cresswell S; McKeown MJ; Boyd LA; Sossi V; Stoessl AJ
Mov Disord; 2019 Dec; 34(12):1891-1900. PubMed ID: 31584222
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
[TBL] [Abstract][Full Text] [Related]
11. Effects of expectation on placebo-induced dopamine release in Parkinson disease.
Lidstone SC; Schulzer M; Dinelle K; Mak E; Sossi V; Ruth TJ; de la Fuente-Fernández R; Phillips AG; Stoessl AJ
Arch Gen Psychiatry; 2010 Aug; 67(8):857-65. PubMed ID: 20679593
[TBL] [Abstract][Full Text] [Related]
12. Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.
Thobois S; Fraix V; Savasta M; Costes N; Pollak P; Mertens P; Koudsie A; Le Bars D; Benabid AL; Broussolle E
J Neurol; 2003 Oct; 250(10):1219-23. PubMed ID: 14586606
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex.
Strafella AP; Paus T; Fraraccio M; Dagher A
Brain; 2003 Dec; 126(Pt 12):2609-15. PubMed ID: 12937078
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.
Abosch A; Kapur S; Lang AE; Hussey D; Sime E; Miyasaki J; Houle S; Lozano AM
Neurosurgery; 2003 Nov; 53(5):1095-102; discussion 1102-5. PubMed ID: 14580276
[TBL] [Abstract][Full Text] [Related]
15. Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study.
Ouchi Y; Yoshikawa E; Futatsubashi M; Okada H; Torizuka T; Sakamoto M
J Cereb Blood Flow Metab; 2002 Jun; 22(6):746-52. PubMed ID: 12045673
[TBL] [Abstract][Full Text] [Related]
16. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
17. Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.
Quattrone A; Barbagallo G; Cerasa A; Stoessl AJ
Mov Disord; 2018 Aug; 33(8):1213-1227. PubMed ID: 30230624
[TBL] [Abstract][Full Text] [Related]
18. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
Steeves TD; Miyasaki J; Zurowski M; Lang AE; Pellecchia G; Van Eimeren T; Rusjan P; Houle S; Strafella AP
Brain; 2009 May; 132(Pt 5):1376-85. PubMed ID: 19346328
[TBL] [Abstract][Full Text] [Related]
19. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
Pedersen K; Simonsen M; Østergaard SD; Munk OL; Rosa-Neto P; Olsen AK; Jensen SB; Møller A; Cumming P
Neuroimage; 2007 Mar; 35(1):38-46. PubMed ID: 17223363
[TBL] [Abstract][Full Text] [Related]
20. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study.
Politis M; Piccini P; Pavese N; Koh SB; Brooks DJ
Exp Neurol; 2008 Nov; 214(1):112-6. PubMed ID: 18723016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
